MedTrace Logo

Improving Perinatal Outcomes Using Conditional and Targeted Transfers

NCT04090762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36607

Last updated 2026-01-13

No results posted yet for this study

Summary

It has been estimated that increasing the use of skilled care during childbirth could prevent up to 1.5 million maternal and newborn deaths and stillbirths by 2025. Conditional cash transfer programs, in which women receive cash payments conditioned on the use of maternal health services, are increasingly being used as a mechanism to increase uptake. In this study, the investigators randomly assign households to receive varying cash amounts conditioned on uptake of recommended pregnancy and delivery care. The investigators crosscut this with an intervention in which pregnant women receive information about their risk type. This randomized trial will provide new evidence about the potential efficacy of targeting cash transfers by pregnancy risk. This study will take place in 288 primary health service areas (HSAs) in Nigeria.

Conditions

  • Utilization, Health Care
  • Birth Outcomes

Interventions

BEHAVIORAL

Conditional cash transfer

Pregnant women receive cash payments conditioned on their use of prenatal services and use of a health facility for child birth.

BEHAVIORAL

Risk information provision

Pregnant women who exhibit characteristics associated with a greater risk of a poor birth outcome - these will be identified from the medical and epidemiological literature - will be informed that they possess these characteristics.

Sponsors & Collaborators

  • RAND

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-08
Primary Completion
2021-06-30
Completion
2025-04-30

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090762 on ClinicalTrials.gov